|Day Low/High||2,550.00 / 2,600.00|
|52 Wk Low/High||2,020.00 / 2,614.00|
Next week brings earnings and more on Deutsche Bank, Cramer says.
Experts say mutual funds' stakes across an industry can thwart competition and that anti-trust regulators should require them to pare their holdings in that case.
Monsanto Company (NYSE: MON) announced it will issue the company's financial results for its fiscal 2016 fourth quarter and full year on Wednesday, Oct.
Buy mutual funds and exchange-traded funds that buy shares of those companies involved in takeovers.
Monsanto's (MON) stock rating was lifted to 'market perform' at Bernstein on Monday morning.
Conditions seem ripe for continued upward momentum in stocks, as long as the Federal Reserve or unexpected shocks don't get in the way.
Monsanto Company (NYSE: MON) announced today that it has reached a global licensing agreement for the use of the CRISPR-Cas genome-editing technology in agriculture with the Broad Institute of MIT and Harvard.
Here are Wednesday's top research calls, including an upgrade for Clovis Oncology, downgrades for Sketchers USA and Wells Fargo and new coverage for Altria.
Monsanto's (MON) stock rating was increased to 'overweight' at JPMorgan on Wednesday morning.
CEO Werner Baumann increases sales and margin forecasts for pharmaceuticals and insists Monsanto deal will deliver growth and improved profit.
Doug Kass shares his thoughts on what goes on his best ideas list and what's still moving down.
Citigroup analysts say Monsanto (MON) was 'left with little choice' but to accept the Bayer (BAYRY) offer, mostly due to the time value of money.
Despite intense opposition from farm groups and skepticism from government enforcers, the merging crop technology giants say they expect to win approval by end of 2017.
Bayer's (BAYRY) $66 billion all-cash takeover of Monsanto (MON) is expected to generate push back from political and regulatory officials who claim it threatens competition in the farm supplier industry.
Another selloff on commodity markets on Wednesday contributed to stock losses throughout the day.
Stocks lose highs by mid-afternoon Wednesday as a selloff in crude resumes.
Here's a technical look at how to trade some of the most active stocks on the market right now.
Jim Cramer says he doesn't think Bayer's proposed acquisition of Monsanto will close.
Bernstein analysts say Monsanto's (MON) $66 billion merger with Bayer (BAYRY) is up against steep antitrust hurdles, resulting in a 50% chance of it being completed.
The CEOs of Monsanto (MON) and Bayer (BAYRY) joined BloombergTV to discuss their $66 billion combination.
Stocks add to slight gains on Wednesday as Wall Street stabilizes after three days of extreme swings.
U.S. stocks gained steam on Wednesday, even though oil prices continued to slide.
Bloomberg Executive editor of global deals Jeff McCracken reacts to the deal in which Bayer (BAYRY) will acquire Monsanto (MON) for $66 billion, or $128 per share.
Stock futures edge higher on Wednesday as Wall Street appears to stabilize after three days of extreme swings.
The agreement values the world's biggest seed maker at $128 per share and comes with a promise of $1.5 billion of annual synergies.
Bayer has agreed to purchase Monsanto for $66 billion, or $128 a share, a 20% premium over its previous closing price.
Monsanto (MON) agreed to be purchased by Bayer (BAYRY) for $66 billion, or $128 per share, in an all-cash deal.
U.S. stock futures point to a slight rebound for Wall Street on Wednesday; report says Bayer to announce acquisition of Monsanto; Wells Fargo CEO John Stumpf says he won't resign.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.